Savara, Inc. is a clinical stage biopharmaceutical company. Specialising in novel therapeutic development and research, Savara operates globally.
Involved in the healthcare sector, Savara’s focus lies within biotech and pharmaceutical services, primarily in rare disease research. Its services encompass development, research, and commercialisation of treatments that offer a better quality of life for patients suffering from rare respiratory illnesses. Savara’s target market is very specific, solely focusing on rare respiratory conditions that require innovative and targeted solutions.
Stay up to date on the share price of SVRA by adding it to your eToro. watchlist.